(NASDAQ: SANA) Sana Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.53%.
Sana Biotechnology's earnings in 2026 is -$211,822,000.On average, 12 Wall Street analysts forecast SANA's earnings for 2026 to be -$211,198,929, with the lowest SANA earnings forecast at -$234,698,739, and the highest SANA earnings forecast at -$188,597,201. On average, 12 Wall Street analysts forecast SANA's earnings for 2027 to be -$185,394,042, with the lowest SANA earnings forecast at -$234,698,739, and the highest SANA earnings forecast at -$135,161,328.
In 2028, SANA is forecast to generate -$191,261,511 in earnings, with the lowest earnings forecast at -$231,765,005 and the highest earnings forecast at -$122,588,181.